University of Memphis Scientists Present Ambrotose AO® Supplement Clinical Study Results at the American College of Sports Medicine’s (ACSM) Annual Meeting
Over 5,000 scientists, thought leaders and students convened in Baltimore, Maryland last week to share scientific progress in the rapidly growing field of sports medicine at the ACSM’s 57th Annual Meeting. At this meeting, University of Memphis scientists presented data from a randomized, double‐blind, placebo‐controlled crossover trial, which showed that Ambrotose AO capsules significantly increased two measures of antioxidant capacity—oxygen radical absorbance capacity (ORAC) and Trolox Equivalent Antioxidant Capacity (TEAC)—in the blood of healthy men and women [1].*† This third human clinical Ambrotose AO study further strengthens the evidence that 4 capsules/day of the product is safe and can improve the antioxidant capacity of human blood. The trial was lead by Dr. Richard J. Bloomer, Associate Professor and Director of the Cardiorespiratory/Metabolic Laboratory in the Department of Health and Sport Sciences at the University of Memphis, Memphis Tennessee and students Cameron G. McCarthy, Robert E. Canale and Kelsey H. Fisher‐Wellman.
ACSM is the largest sports medicine and exercise science organization in the world, and ACSM members are the industry’s foremost health and fitness experts. The meeting was held June 1–5, 2010 in conjunction with the inaugural meeting of the World Congress on Exercise is Medicine™.
